With the growing popularity of GLP-1 receptor agonists for weight loss and metabolic health, many people are now hearing about a new peptide called retatrutide
After four weeks, dosing adjustments depend on three markers: patient-reported sustained energy (indicating mitochondrial carnitine sufficiency), weight loss velocity (indicating hepatic lipid mobilisation), and subjective appetite control (indicating phosphatidylcholine-mediated satiety hormone signaling)
This is exactly why controlled trials are needed and why microdosing should be approached with appropriate medical supervision, not self-experimented with based on internet articles alone
Fortunately, these side effects often settle as the body adapts to the medication." What other side-effects can Ozempic cause
The drug candidate acts as an agonist of the glucagon-like peptide-1 (GLP-1) receptor, following the same mode of action as Mounjaro (tirzepatide), the companys peptide-based GLP-1 drug for weight loss